Filing Details
Axsome Therapeutics, Inc. (NASDAQ:AXSM) filed a Form 8-K with the Securities and Exchange Commission on July 15, 2026, disclosing a material event.
8k filedNASDAQ:AXSM
Axsome Therapeutics, Inc. (AXSM) Reports Material Event to SEC
Filing Details Axsome Therapeutics, Inc. (NASDAQ:AXSM) filed a Form 8-K with the Securities and Exchange Commission on July 15, 2026, disclosing a material event. Market Context…
Market Context
Axsome Therapeutics, Inc.'s stock currently trades at $237.53 with a market capitalization of $7.5B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Axsome Therapeutics, Inc.'s stock.
All SEC filings for Axsome Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View AXSM Stock Page
Frequently Asked Questions
Where can I read AXSM's SEC filings?
Browse all filings on our AXSM SEC filings page.
What types of SEC filings does Axsome Therapeutics, Inc. file?
Public companies like Axsome Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
